CINFINI Trademark

Trademark Overview

On Friday, September 20, 2013, a trademark application was filed for CINFINI with the United States Patent and Trademark Office. The USPTO has given the CINFINI trademark a serial number of 86070901. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2017. This trademark is owned by Novartis AG. The CINFINI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
cinfini

General Information

Serial Number86070901
Word MarkCINFINI
Filing DateFriday, September 20, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, July 31, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 31, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 6, 2017EXTENSION 5 GRANTED
Thursday, December 22, 2016EXTENSION 5 FILED
Thursday, December 22, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 2, 2016EXTENSION 4 GRANTED
Friday, June 17, 2016EXTENSION 4 FILED
Friday, June 17, 2016TEAS EXTENSION RECEIVED
Friday, January 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 14, 2016EXTENSION 3 GRANTED
Monday, December 21, 2015EXTENSION 3 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Thursday, July 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 15, 2015EXTENSION 2 GRANTED
Tuesday, June 16, 2015EXTENSION 2 FILED
Tuesday, July 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 16, 2015TEAS EXTENSION RECEIVED
Thursday, December 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 23, 2014EXTENSION 1 GRANTED
Tuesday, December 23, 2014EXTENSION 1 FILED
Tuesday, December 23, 2014TEAS EXTENSION RECEIVED
Tuesday, June 24, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 20, 2014ASSIGNED TO LIE
Thursday, March 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 6, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, March 6, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, January 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 2, 2014NON-FINAL ACTION E-MAILED
Thursday, January 2, 2014NON-FINAL ACTION WRITTEN
Tuesday, December 31, 2013ASSIGNED TO EXAMINER
Friday, September 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

cinfini disorders system treatment diseases preparations pharmaceutical biological anti prevention autoimmune